Leonard B, Shallice S
Br J Pharmacol. 1971; 41(2):198-212.
PMID: 5572273
PMC: 1703283.
DOI: 10.1111/j.1476-5381.1971.tb08022.x.
Leonard B, Shallice S
Br J Pharmacol. 1971; 43(4):732-8.
PMID: 5152025
PMC: 1665720.
DOI: 10.1111/j.1476-5381.1971.tb07208.x.
Leonard B, Stonier P
Psychopharmacologia. 1971; 22(2):126-32.
PMID: 5124186
DOI: 10.1007/BF00403620.
Leonard B
Br J Pharmacol. 1972; 45(1):165P-166P.
PMID: 5041482
PMC: 1666216.
Leonard B, Stonier P
Psychopharmacologia. 1972; 25(1):1-13.
PMID: 5038979
DOI: 10.1007/BF00422611.
Interaction of phencyclidine with drugs affecting noradrenaline metabolism in the rat brain.
Tonge S, Leonard B
Psychopharmacologia. 1972; 23(1):86-90.
PMID: 5018980
DOI: 10.1007/BF00414416.
Some effects of a new tetracyclic anti-depressant compound, Org GB 94, on the metabolism of monoamines in the rat brain.
Leonard B
Psychopharmacologia. 1974; 36(3):221-36.
PMID: 4846327
DOI: 10.1007/BF00421804.
Some effects of the hallucinogenic drug 2, 5-dimethoxy-4-methyl amphetamine on the metabolism of biogenic amines in the rat brain.
Leonard B
Psychopharmacologia. 1973; 32(1):33-49.
PMID: 4743235
DOI: 10.1007/BF00421706.
Permanent alterations in catecholamine concentrations in discrete areas of brain in the offspring of rats treated with methylamphetamine and chlorpromazine.
Tonge S
Br J Pharmacol. 1973; 47(2):425-7.
PMID: 4722052
PMC: 1776536.
DOI: 10.1111/j.1476-5381.1973.tb08341.x.
Reversal learning enhanced by lysergic acid diethylamide (LSD): concomitant rise in brain 5-hydroxytryptamine levels.
King A, Martin I, Melville K
Br J Pharmacol. 1974; 52(3):419-26.
PMID: 4458849
PMC: 1777004.
DOI: 10.1111/j.1476-5381.1974.tb08611.x.
Acute and chronic effects of 4-chloroamphetamine on monoamine metabolism in the rat brain.
Leonard B
Psychopharmacologia. 1976; 46(1):11-8.
PMID: 1257360
DOI: 10.1007/BF00421543.
Effects of single and multiple dose LSD on endogenous levels of brain tyrosine and catecholamines.
Smith R, Boggan W, Freedman D
Psychopharmacologia. 1975; 42(3):271-6.
PMID: 1161985
DOI: 10.1007/BF00421267.
Monamines in brain and urine of rats with hereditary hypothalamic diabetes insipidus.
Leonard B, Ramaekers F, Rigter H
Experientia. 1976; 32(7):901-2.
PMID: 954977
DOI: 10.1007/BF02003756.
Effects of chronic (+/-)-propranolol on catecholamines and GABA in rat striatum [proceedings].
Morinan A, Leonard B
Br J Pharmacol. 1977; 61(1):152P.
PMID: 912201
PMC: 1667685.
Effect of D-amphetamine on the behaviour of rats in the open field apparatus: interaction with four neuroleptics and changes in biogenic amine metabolsm in discrete brain regions.
Lynch M, Kenny M, Leonard B
Ir J Med Sci. 1978; 147(10):337-50.
PMID: 711421
DOI: 10.1007/BF02939429.
Social isolation in the young rat: neurochemical correlates of chronic amphetamine treatment.
Morinan A
Ir J Med Sci. 1978; 147 Suppl 1:53-6.
PMID: 689853
DOI: 10.1007/BF02947905.
Some neuropharmacological aspects of schizophrenia: a short review.
Leonard B, Kenny M
Ir J Med Sci. 1978; 147 Suppl 1:43-8.
PMID: 567632
DOI: 10.1007/BF02947903.
On the interaction of drugs with the cholinergic nervous system. II. Cross-tolerance between phencyclidine derivatives and cholinergic drugs.
Pinchasi I, Maayani S, Egozi Y, Sokolovsky M
Psychopharmacology (Berl). 1978; 56(1):37-40.
PMID: 415324
DOI: 10.1007/BF00571405.
Parachlorophenylalanine potentiates facilitatory effects of mescaline on shuttlebox escape/avoidance in rats.
Stoff D, Wyatt R, Gillin J
Psychopharmacology (Berl). 1976; 47(3):287-92.
PMID: 135268
DOI: 10.1007/BF00427615.
Effects of mescaline and amphetamine on simultaneous visual discrimination in two inbred strains of mice.
Castellano C
Psychopharmacology (Berl). 1979; 62(1):35-40.
PMID: 108746
DOI: 10.1007/BF00426032.
